{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:50:41Z","timestamp":1782226241965,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,4,7]],"date-time":"2008-04-07T00:00:00Z","timestamp":1207526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,4,7]],"date-time":"2008-04-07T00:00:00Z","timestamp":1207526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1038\/bmt.2008.94","type":"journal-article","created":{"date-parts":[[2008,4,7]],"date-time":"2008-04-07T11:14:00Z","timestamp":1207566840000},"page":"99-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Allo-SCT using reduced-intensity conditioning against advanced pancreatic cancer: a Japanese survey"],"prefix":"10.1038","volume":"42","author":[{"given":"Y","family":"Kanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Omuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Nagafuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Heike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Takaue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,7]]},"reference":[{"key":"BFbmt200894_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1046\/j.1365-2141.2000.02196.x","volume":"111","author":"R Champlin","year":"2000","unstructured":"Champlin R, Khouri I, Shimoni A, Gajewski J, Kornblau S, Molldrem J et al. Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy. Br J Haematol 2000; 111: 18\u201329.","journal-title":"Br J Haematol"},{"key":"BFbmt200894_CR2","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/sj.leu.2403770","volume":"19","author":"M Mohty","year":"2005","unstructured":"Mohty M, de Lavallade H, Ladaique P, Faucher C, Vey N, Coso D et al. The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison. Leukemia 2005; 19: 916\u2013920.","journal-title":"Leukemia"},{"key":"BFbmt200894_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/sj.bmt.1705479","volume":"38","author":"M Bregni","year":"2006","unstructured":"Bregni M, Ueno NT, Childs R . The second international meeting on allogeneic transplantation in solid tumors. Bone Marrow Transplant 2006; 38: 527\u2013537.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200894_CR4","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/blood-2003-04-1022","volume":"102","author":"NT Ueno","year":"2003","unstructured":"Ueno NT, Cheng YC, Rondon G, Tannir NM, Gajewski JL, Couriel DR et al. Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors. Blood 2003; 102: 3829\u20133836.","journal-title":"Blood"},{"key":"BFbmt200894_CR5","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1182\/blood.V99.11.4234","volume":"99","author":"M Bregni","year":"2002","unstructured":"Bregni M, Dodero A, Peccatori J, Pescarollo A, Bernardi M, Sassi I et al. Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer. Blood 2002; 99: 4234\u20134236.","journal-title":"Blood"},{"key":"BFbmt200894_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1056\/NEJM200009143431101","volume":"343","author":"R Childs","year":"2000","unstructured":"Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000; 343: 750\u2013758.","journal-title":"N Engl J Med"},{"key":"BFbmt200894_CR7","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","volume":"15","author":"HA Burris III","year":"1997","unstructured":"Burris III HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15: 2403\u20132413.","journal-title":"J Clin Oncol"},{"key":"BFbmt200894_CR8","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1200\/JCO.2006.09.0886","volume":"25","author":"R Herrmann","year":"2007","unstructured":"Herrmann R, Bodoky G, Ruhstaller T, Glimelius B, Bajetta E, Schuller J et al. Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group. J Clin Oncol 2007; 25: 2212\u20132217.","journal-title":"J Clin Oncol"},{"key":"BFbmt200894_CR9","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1200\/JCO.2002.11.149","volume":"20","author":"JD Berlin","year":"2002","unstructured":"Berlin JD, Catalano P, Thomas JP, Kugler JW, Haller DG, Benson III AB . Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297. J Clin Oncol 2002; 20: 3270\u20133275.","journal-title":"J Clin Oncol"},{"key":"BFbmt200894_CR10","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1200\/JCO.2005.05.1490","volume":"24","author":"V Heinemann","year":"2006","unstructured":"Heinemann V, Quietzsch D, Gieseler F, Gonnermann M, Schonekas H, Rost A et al. Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer. J Clin Oncol 2006; 24: 3946\u20133952.","journal-title":"J Clin Oncol"},{"key":"BFbmt200894_CR11","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","volume":"25","author":"MJ Moore","year":"2007","unstructured":"Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007; 25: 1960\u20131966.","journal-title":"J Clin Oncol"},{"key":"BFbmt200894_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0889-8588(01)00002-8","volume":"16","author":"HL Kaufman","year":"2002","unstructured":"Kaufman HL, Di Vito Jr J, Horig H . Immunotherapy for pancreatic cancer: current concepts. Hematol Oncol Clin North Am 2002; 16: 159\u2013197, viii.","journal-title":"Hematol Oncol Clin North Am"},{"key":"BFbmt200894_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/sj.bmt.1703932","volume":"31","author":"Y Omuro","year":"2003","unstructured":"Omuro Y, Matsumoto G, Sasaki T, Tanaka Y, Maeda Y, Sakamaki H et al. Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. Bone Marrow Transplant 2003; 31: 943\u2013945.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200894_CR14","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1097\/00006676-200404000-00027","volume":"28","author":"T Takahashi","year":"2004","unstructured":"Takahashi T, Omuro Y, Matsumoto G, Sakamaki H, Maeda Y, Hiruma K et al. Nonmyeloablative allogeneic stem cell transplantation for patients with unresectable pancreatic cancer. Pancreas 2004; 28: e65\u2013e69.","journal-title":"Pancreas"},{"key":"BFbmt200894_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/01.TP.0000153507.94980.A5","volume":"79","author":"Y Kanda","year":"2005","unstructured":"Kanda Y, Komatsu Y, Akahane M, Kojima S, Asano-Mori Y, Tada M et al. Graft-versus-tumor effect against advanced pancreatic cancer after allogeneic reduced-intensity stem cell transplantation. Transplantation 2005; 79: 821\u2013827.","journal-title":"Transplantation"},{"key":"BFbmt200894_CR16","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/sj.bmt.1701779","volume":"23","author":"C Thiede","year":"1999","unstructured":"Thiede C, Florek M, Bornhauser M, Ritter M, Mohr B, Brendel C et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant 1999; 23: 1055\u20131060.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200894_CR17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/sj.bmt.1704019","volume":"31","author":"S Heimfeld","year":"2003","unstructured":"Heimfeld S . HLA-identical stem cell transplantation: is there an optimal CD34 cell dose? Bone Marrow Transplant 2003; 31: 839\u2013845.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200894_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s002620050508","volume":"47","author":"C Kim","year":"1998","unstructured":"Kim C, Matsumura M, Saijo K, Ohno T . In vitro induction of HLA-A2402-restricted and carcinoembryonic-antigen-specific cytotoxic T lymphocytes on fixed autologous peripheral blood cells. Cancer Immunol Immunother 1998; 47: 90\u201396.","journal-title":"Cancer Immunol Immunother"},{"key":"BFbmt200894_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/00000658-199004000-00011","volume":"211","author":"M Trede","year":"1990","unstructured":"Trede M, Schwall G, Saeger HD . Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990; 211: 447\u2013458.","journal-title":"Ann Surg"},{"key":"BFbmt200894_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0002-9610(05)80406-4","volume":"165","author":"RJ Geer","year":"1993","unstructured":"Geer RJ, Brennan MF . Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 165: 68\u201372; discussion 72\u201363.","journal-title":"Am J Surg"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt200894.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt200894","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt200894.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:14:59Z","timestamp":1648037699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt200894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,7]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["BFbmt200894"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2008.94","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,7]]},"assertion":[{"value":"28 January 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}